Keyphrases
Coronary Artery Disease
100%
Chest Pain
57%
Randomized Controlled Trial
51%
Myocardial Perfusion
49%
Coronary Computed Tomography Angiography
49%
Obstructive Coronary Artery Disease
41%
Invasive Coronary Angiography
36%
Stable Angina
32%
Non-invasive Test
31%
Acute Chest Syndrome
28%
Cardiac Computed Tomography
28%
Treatment Strategy
27%
Invasive Treatment
26%
Invasive Examination
26%
Computed Tomography Perfusion
26%
Acute Onset
26%
Angina
26%
PCSK9 Inhibitors
24%
Hospital-based
24%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
24%
Coronary Angiography
24%
Troponin
24%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
24%
Valvular Heart Disease
24%
Suspected Coronary Artery Disease
24%
Multi-slice Computed Tomography
24%
Multidetector Computed Tomography
24%
Guided Therapy
24%
Evolocumab
24%
Patient Management
24%
Perfusion Assessment
24%
Prediction Model
24%
Diagnostic Performance
24%
Risk Stratification
24%
Clinical Management
24%
Early Invasive Strategy
19%
C-statistic
18%
Pre-test Probability
18%
Odds Ratio
16%
Diagnostic Approach
16%
Medicine and Dentistry
Coronary Artery Disease
86%
Coronary Angiography
56%
Thorax Pain
52%
Randomized Controlled Trial
51%
Coronary Computed Tomography Angiography
49%
Heart Muscle Perfusion
49%
Multidetector Computed Tomography
45%
Diagnosis
37%
Computer Assisted Tomography
31%
Stable Angina Pectoris
28%
Acute Coronary Syndrome
26%
Valvular Heart Disease
24%
Clinical Management
24%
ST Elevation
24%
Coronary Risk
24%
Risk Stratification
24%
Angina pectoris
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
80%
Thorax Pain
29%
Acute Coronary Syndrome
29%
Randomized Controlled Trial
29%
Stable Angina Pectoris
28%
Troponin T
24%
Brain Natriuretic Peptide
24%
